On this page
Vaginal Candidiasis: Symptoms, Treatment, Remedies, and Prevention
What is Candidiasis?
Candidiasis (also called candidosis) is a fungal infection caused by yeasts belonging to the genus Candida. At least 20 different species are capable of causing infections in humans, but the most common by far is Candida albicans.
Vaginal yeast infections are extremely common among adolescents and adult women. It is estimated that approximately 75% of all women will experience at least one episode of vaginal candidiasis at some point in their lives, and nearly half of those will have a second episode.
The symptoms of a vaginal yeast infection can include:
- Itching and irritation affecting the vulva and vagina
- Thick, white, odorless vaginal discharge with the consistency of cottage cheese
- A burning sensation, particularly during sexual intercourse and urination
- Redness and swelling of the vulva
- Pain and discomfort
- Watery vaginal discharge
Not all symptoms are necessarily present at the same time, and their severity varies considerably from one episode to another and from one patient to another.
In most cases, yeast infections can be prevented by keeping the genital area clean and dry. When an infection does occur, a doctor can prescribe appropriate antifungal therapy that typically resolves symptoms within one to two days and clears the infection within a week. Antifungal medications are effective in the majority of patients, although treatment may be more challenging in individuals with weakened immune systems.
Causes: How Do You Get a Yeast Infection?
The fungus Candida is the causative agent of the infection that bears its name.
Under normal conditions, the vagina harbors a balanced community of yeasts (including Candida) and bacteria. Lactobacilli — the dominant beneficial bacteria in the healthy vaginal microbiome — produce lactic acid and other substances that maintain an acidic vaginal pH, which in turn prevents the overgrowth of yeast. When this delicate microbial balance is disrupted, yeast can proliferate excessively, triggering the characteristic symptoms of itching, burning, and abnormal discharge.
The most common responsible pathogen is Candida albicans, which accounts for approximately 90% of all cases. Most of the remaining cases are caused by Candida glabrata (now reclassified as Nakaseomyces glabrata), which is generally associated with milder symptoms but is often more resistant to standard antifungal treatments.
Candida thrives in warm, moist, dark environments. Clothing that is too tight or made of synthetic materials such as nylon — which trap heat and moisture — can create conditions that favor the development of infection.
With puberty and hormonal development, fluctuating hormone levels can increase girls’ susceptibility to yeast infections: episodes sometimes occur just before menstruation, when estrogen levels change.
Pregnant women are also at significantly higher risk of yeast infections due to hormonal changes that alter vaginal pH and discharge composition. However, vaginal candidiasis during pregnancy is not generally considered dangerous to the pregnancy itself.
Candidiasis is less common in prepubertal girls, but it can still occur. If your daughter complains of itching or discomfort in the vaginal area, it is important to consult a pediatrician.
Although yeast infections can develop following certain sexual practices — such as oral-genital contact — they are not classified as sexually transmitted infections (STIs) by most gynecologists, since women who are not sexually active can also develop yeast infections. The overgrowth of Candida is an endogenous process rather than a classic transmission event.
Risk Factors
Yeast infections occur more frequently and with more severe symptoms in individuals with weakened immune systems. Other predisposing factors include:
- Antibiotic therapy: Antibiotics reduce the protective Lactobacilli in the vagina, disrupting the microbial balance and altering vaginal pH, creating an environment favorable to yeast overgrowth
- Use of inappropriate hygiene products: Scented soaps, shower gels, or vaginal douches that disturb the natural vaginal environment
- Pregnancy: Hormonal changes alter vaginal secretion composition and pH
- Diabetes mellitus: Particularly when blood glucose levels are poorly controlled, as elevated glucose in vaginal secretions provides an ideal growth medium for yeast
- Impaired immune system: Due to conditions such as HIV/AIDS or immunosuppressive medications including chemotherapy, corticosteroids, and antibiotics
- Chronic stress: Which can suppress immune function and alter hormonal balance
- Obesity: Due to excess circulating estrogens, which can promote yeast proliferation
- Oral contraceptives or hormonal therapies that increase estrogen levels, which can alter the vaginal environment
Other Types of Candida Infection
Candida yeasts normally colonize the gastrointestinal tract and can also be found on mucous membranes and skin without causing infection. However, when their growth becomes excessive, they can trigger disease in various anatomical sites. Warm, moist areas of the body and areas prone to sweating are particularly vulnerable. The main forms of candidiasis outside the vagina include:
- Oropharyngeal candidiasis (thrush): Infection of the mouth or throat; presents as white, creamy patches on the tongue and inner cheeks. Learn more about oral thrush.
- Esophageal candidiasis: Infection spreading to the esophagus (the tube connecting the mouth to the stomach), causing difficulty or pain on swallowing. Learn more about esophagitis.
- Intestinal candidiasis: Infection of the intestinal tract, causing gastrointestinal symptoms.
- Cutaneous candidiasis: Skin infection, typically affecting skin folds (groin, underarms, under the breasts), presenting as red, irritated rashes.
- Vaginal candidiasis: The focus of this article. In men, Candida infection of the genitals typically causes balanoposthitis (infection of the glans and foreskin of the penis).
- Invasive candidiasis: A serious, potentially life-threatening condition in which Candida enters the bloodstream (candidemia) and spreads to internal organs. This form occurs almost exclusively in immunocompromised individuals or patients in intensive care settings.
Symptoms
Women with vaginal candidiasis typically report irritation, itching, and burning as their primary complaints.
Symptoms tend to worsen just before the menstrual period, when hormonal fluctuations alter the vaginal environment.
On gynecological examination, the clinician typically observes:
- Vulvar and vaginal erythema (redness) and swelling
- Signs of irritation and excoriation from scratching
- The characteristic thick, white, cottage cheese-like discharge
The intensity of symptoms is variable: some women experience only mild discomfort, while others have severely distressing symptoms that significantly affect daily life and sexual function.
How to Tell a Yeast Infection Apart from a UTI
Because the two types of infection can share overlapping symptoms — for example, both cystitis (urinary tract infection) and vaginal candidiasis can cause a burning sensation during urination — it is essential to consult a doctor to determine the precise cause of symptoms and ensure appropriate treatment.
Key distinguishing features:
- Vaginal candidiasis typically causes predominant external burning (at the vulvar opening), thick white cottage cheese-like discharge, and significant vulvar itching, without urinary frequency or urgency
- Cystitis typically causes burning during urination (felt inside the urethra), frequent and urgent need to urinate, and possibly cloudy or malodorous urine, without the thick white discharge characteristic of a yeast infection
Self-diagnosis is unreliable. Since these conditions require different treatments, professional evaluation is always recommended.
Candidiasis During Pregnancy
Vaginal yeast infections during pregnancy are very common — likely more so than at any other stage of a woman’s life. This is primarily due to the profound hormonal changes of pregnancy, which alter the composition and pH of cervical mucus, making the vaginal environment more favorable to yeast overgrowth. The second trimester is the period most frequently affected.
Treatment can be safely planned during pregnancy. Multiple topical antifungal treatments have been demonstrated to be safe for use during gestation. Fortunately, vaginal candidiasis during pregnancy does not generally cause complications for either the mother or the fetus.
Important: Oral antifungal medications (particularly fluconazole) are generally not recommended during pregnancy, especially in the first trimester, due to concerns about potential fetal effects. Pregnant women should always consult their obstetrician or midwife before using any treatment.
Complications
Symptoms of vaginal candidiasis, while typically not dangerous to overall health, can be significantly distressing and may persist over time if inadequately treated. Key complications and concerns include:
- Recurrent infections: Some women experience four or more episodes per year (recurrent vulvovaginal candidiasis — RVVC), which can cause considerable psychological distress, sexual dysfunction, and reduced quality of life
- Antifungal resistance: There is growing concern regarding multi-drug resistant Candida strains, particularly Candida glabrata and the emerging pathogen Candida auris, which may fail to respond to standard antifungal therapies and require specialist management
- Psychological impact: Chronic or recurrent candidiasis can have a significant negative effect on a woman’s psychological wellbeing, self-esteem, and intimate relationships
- Sexual transmission: While vaginal candidiasis is not classified as an STI, there is a possibility of transmission to sexual partners, who may develop symptoms and may require treatment if they are symptomatic. Male partners can develop candidal balanitis.
Despite these concerns, vaginal candidiasis is not associated with major systemic health risks in immunocompetent women. It does not cause infertility, does not spread to internal organs, and does not increase the risk of cervical cancer.
Diagnosis
The diagnosis of vaginal candidiasis should never be based on self-assessment of symptoms alone, as these frequently overlap with other conditions such as bacterial vaginosis, trichomoniasis, or other sexually transmitted infections. Accurate clinical diagnosis is essential to avoid inappropriate treatments, which can promote the development of antifungal resistance and delay effective care.
The standard diagnostic protocol includes:
-
Gynecological examination: The clinician assesses the characteristic clinical signs, including vulvar and vaginal erythema, swelling, and the presence of the typical thick, white, curdy discharge
-
Vaginal pH measurement: In uncomplicated candidiasis, the vaginal pH typically remains within the normal acidic range (below 4.5). A pH above 4.5 suggests bacterial vaginitis or Trichomonas infection rather than candidiasis
-
Microscopic wet preparation: A small sample of vaginal discharge is examined under the microscope, often with the addition of potassium hydroxide (KOH), which dissolves cellular debris and makes fungal elements easier to visualize. This allows immediate identification of Candida hyphae, pseudohyphae, or budding yeast cells, confirming the clinical diagnosis
-
Vaginal swab and culture: Not necessary in all cases, but becomes essential in the presence of persistent or severe symptoms, frequent recurrences, or failure to respond to initial therapy. Culture allows precise species identification (for example, detecting non-albicans species such as C. glabrata) and enables antifungal susceptibility testing (antimycogram) to guide appropriate treatment
It is important to note that the incidental finding of Candida on a routine screening test (such as a cervical smear/Pap test) in a completely asymptomatic woman does not generally require treatment, as the fungus can be part of the normal vaginal microbial flora without causing disease.
Treatment and Remedies
The therapeutic goal in vaginal candidiasis is to eradicate the excessive yeast overgrowth and restore the health and comfort of the vaginal mucosa. The management approach varies significantly depending on whether this is an isolated episode or a recurrent form (defined as four or more episodes within a single year).
First-Line Pharmacological Treatments
For mild to moderate infections, validated therapeutic options include:
-
Topical (local) treatments: Vaginal ovules, pessaries, or creams containing azole antifungal agents (such as clotrimazole, miconazole, or econazole). Treatment duration varies from a single “one-dose” application to 3-day or 7-day courses. These formulations act directly on the vaginal mucosa and are generally preferred for their rapid local action and minimal systemic side effects. They are considered safe for use during pregnancy (under medical supervision).
-
Oral treatments: A single oral dose of fluconazole 150 mg is considered as effective as topical treatments and is often preferred by patients for its convenience. However, during pregnancy, the prevailing clinical guidance recommends exclusive use of topical treatments as a precautionary measure. Oral fluconazole is contraindicated or should be used with caution in the first trimester of pregnancy.
The choice between topical and oral therapy should be guided by the severity of symptoms, patient preference, pregnancy status, and any relevant contraindications.
Managing Recurrent or Complicated Candidiasis
In cases of recurrent infection or infections caused by non-albicans Candida species, management requires a more structured strategy. This typically involves:
- An intensive induction phase: A more prolonged initial treatment course (7 to 14 days of topical therapy, or multiple doses of oral antifungal medication) to achieve complete eradication
- A maintenance suppressive phase: Typically a weekly dose of an oral antifungal agent (most commonly fluconazole) for six months, aimed at preventing relapse
In selected cases of azole-resistant infections — particularly those caused by C. glabrata — the clinician may prescribe boric acid vaginal preparations (available as compounded suppositories), which must be used under strict specialist supervision. Boric acid is toxic if swallowed and must never be taken orally.
Identifying and addressing modifiable underlying risk factors (such as optimizing diabetes management, reviewing antibiotic use, or adjusting hormonal contraception) is an important component of managing recurrent disease.
Lifestyle Measures and Support for Recovery
The effectiveness of antifungal medications is significantly supported by daily habits that make the vaginal environment less hospitable to yeast overgrowth:
-
Intimate hygiene: Use mild, unfragranced cleansers specifically formulated for intimate hygiene with an acidic pH (approximately 3.5 to 4.5). Avoid vaginal douching entirely — douching disrupts the protective vaginal flora and is consistently associated with adverse gynecological outcomes, including increased infection risk.
-
Clothing: Choose white cotton underwear that is breathable and allows air circulation. Avoid prolonged use of synthetic panty liners, tights, or excessively tight-fitting trousers that create a warm, moist microclimate.
-
Diet: While no “anti-candida diet” has been proven definitively effective in clinical trials, there is scientific consensus supporting the reduction of excess simple sugars in the diet, as high glucose levels in vaginal secretions can promote yeast proliferation — particularly relevant for diabetic patients.
-
Complementary remedies: External washing with a dilute sodium bicarbonate solution may provide temporary relief from intense itching due to its soothing and mildly alkalizing action, but does not have direct antifungal activity and should not replace prescribed treatment. Supplementation with specific probiotic strains (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) may help restore the vaginal microbiome after antifungal therapy, though evidence quality remains moderate and their use should be discussed with a clinician.
Prevention
In the majority of cases, vaginal yeast infections can be prevented through simple, evidence-based hygiene practices:
- Use mild, unfragranced soaps and avoid any type of vaginal spray, deodorant, or douche. For some women, certain bath gels, lotions, or laundry detergents can cause vaginal irritation that in turn predisposes to candidiasis. Gentle, pH-balanced intimate hygiene products are recommended.
- After swimming or physical exercise — particularly in tight, damp swimwear or sportswear — change promptly out of wet or sweaty clothing into clean, dry clothes. Prolonged contact with moisture is a key risk factor.
- Wipe from front to back after using the toilet to avoid transferring intestinal bacteria (and Candida from the gut) to the vaginal area.
- Avoid unnecessary antibiotic use and, when antibiotics are genuinely required, discuss with your doctor whether concurrent antifungal prophylaxis is appropriate.
- Maintain good blood glucose control if you have diabetes, as hyperglycemia significantly increases yeast infection risk.
- Some sources recommend a low-carbohydrate diet for prevention, but clinical evidence supporting this is limited. What is broadly supported is improving the overall quality of carbohydrate intake — reducing refined sugars and sweets while choosing wholegrain alternatives — rather than eliminating carbohydrates entirely.
Clothing Choices
Thoughtful clothing choices are an underrated but effective component of yeast infection prevention:
- Wear cotton underwear that does not trap moisture and allows adequate air circulation around the genital area
- Avoid synthetic fabrics such as nylon, polyester, and lycra for underwear, as these trap heat and moisture
- Avoid very tight-fitting clothing such as skinny jeans, tight leggings, and tights for prolonged periods, as they create a warm, humid microenvironment that favors Candida overgrowth
- Sleep without underwear when possible, to allow nighttime ventilation of the vaginal area
Sources and Bibliography
- NIH - National Institute of Allergy and Infectious Diseases: Vaginal Candidiasis
- NORD - Rare Diseases: Candidiasis
- Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961-1971.
- Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016;62(4):e1-e50.
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
- Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database of Systematic Reviews. 2001.
- Centers for Disease Control and Prevention (CDC). Vaginal Candidiasis. Available at: https://www.cdc.gov/fungal/diseases/candidiasis/genital/index.html
- European Centre for Disease Prevention and Control (ECDC). Candida infections: epidemiology and antifungal resistance surveillance.
